This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Greg Lazar: Innovator in Antibody Technology
Introduction
Greg Lazar is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of multivalent and multiepitopic antibodies. With a total of 2 patents, Lazar's work has advanced the understanding and application of antibody technology.
Latest Patents
Lazar's latest patents include "Multivalent and multiepitopic antibodies having agonistic activity and methods of use." This patent describes tetravalent antigen binding complexes that exhibit agonist activity for a cell surface receptor. The complexes are designed to have binding specificities for multiple epitopes of the same receptor. Additionally, the patent covers nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production related to these complexes. Another notable patent is "Antigen binding complex having agonistic activity and methods of use," which details antigen binding polypeptides and complexes with agonist activity. This patent also outlines methods for screening complexes or polypeptides with agonist activity and enhancing the agonist activity of a polypeptide.
Career Highlights
Throughout his career, Greg Lazar has worked with leading companies in the biotechnology sector, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with some of the brightest minds in the industry.
Collaborations
Lazar has had the opportunity to work alongside talented colleagues such as Yanli Yang and Jeong Kim. Their collaborative efforts have contributed to the advancement of innovative solutions in antibody technology.
Conclusion
Greg Lazar's contributions to the field of biotechnology, particularly in antibody technology, have been significant. His patents reflect a deep understanding of complex biological systems and a commitment to advancing medical science. His work continues to influence the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile